Profil
Michael Jung is the founder of Aragon Pharmaceuticals, Inc. (founded in 2009) and Seragon Pharmaceuticals, Inc. (founded in 2013).
He is also the founder of Enlibrium, Inc. Dr. Jung's current job is as a Professor at the University of California, Berkeley.
Aktive Positionen von Michael Jung
| Unternehmen | Position | Beginn |
|---|---|---|
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 07.04.2010 |
Enlibrium, Inc.
Enlibrium, Inc. Medical/Nursing ServicesHealth Services Provides medical services | Gründer | - |
Ehemalige bekannte Positionen von Michael Jung
| Unternehmen | Position | Ende |
|---|---|---|
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Gründer | - |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Health Technology |
Enlibrium, Inc.
Enlibrium, Inc. Medical/Nursing ServicesHealth Services Provides medical services | Health Services |
















